Early Infectious Disease Outpatient Follow-up of Outpatient Parenteral Antimicrobial Therapy Patients Reduces 30-Day Readmission. (4th February 2019)

• Record Type: Journal Article
• Authors: Saini, Ena; Ali, Mohammad; Du, Ping; Crook, Tonya; Zurlo, John
• Is Part Of: Clinical infectious diseases. Volume 69:Number 5(2019)
• Page Start: 865
• Page End: 868
• Publication Date: 2019-02-04
• Subjects: outpatient parenteral antimicrobial therapy; OPAT -- infectious disease follow-up -- 30-day readmission; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciz073
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: We conducted a case-control study to examine the association between outpatient infectious disease (ID) follow-up and risk of 30-day readmission in 384 patients receiving outpatient parenteral antimicrobial therapy. ID outpatient follow-up within 2 weeks was associated with lower risk of all-cause 30-day readmission (adjusted odds ratio, 0.33; P = .0001).